Use of Artificial Intelligence in Imaging Dementia
Cells · 2024
DOI: 10.3390/cells13231965 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, 2024. Verfasst von Manal Aljuhani und 2 weiteren Autor:innen. Beteiligte Einrichtung: Radiological Science and Medical Imaging Department, College of Applied Medical Sciences, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Sau…. Hauptthemen laut MEDLINE: Artificial Intelligence, Dementia, Neuroimaging. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Prince Sattam bin Abdulaziz University.
Abstract (Originalsprache)
Alzheimer’s disease is the most common cause of dementia in the elderly population (aged 65 years and over), followed by vascular dementia, Lewy body dementia, and rare types of neurodegenerative diseases, including frontotemporal dementia. There is an unmet need to improve diagnosis and prognosis for patients with dementia, as cycles of misdiagnosis and diagnostic delays are challenging scenarios in neurodegenerative diseases. Neuroimaging is routinely used in clinical practice to support the diagnosis of neurodegenerative diseases. Clinical neuroimaging is amenable to errors owing to varying human judgement as the imaging data are complex and multidimensional. Artificial intelligence algorithms (machine learning and deep learning) enable automation of neuroimaging interpretation and may reduce potential bias and ameliorate clinical decision-making. Graph convolutional network-based frameworks implicitly provide multimodal sparse interpretability to support the detection of Alzheimer’s disease and its prodromal stage, mild cognitive impairment. In patients with amyloid-related imaging abnormalities, radiologists had significantly better detection performances with both ARIA-E (sensitivity higher in the assisted/deep learning method [87%] compared to unassisted [71%]) and for ARIA-H signs (sensitivity was higher in assisted [79%] compared to unassisted [69%]). A convolutional neural network method was developed, and external validation predicted final clinical diagnoses of Alzheimer’s disease, dementia with Lewy bodies, mild cognitive impairment due to Alzheimer’s disease, or cognitively normal with FDG-PET. The translation of artificial intelligence to clinical practice is plagued with technical, disease-related, and institutional challenges. The implementation of artificial intelligence methods in clinical practice has the potential to transform the diagnostic and treatment landscape and improve patient health and outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Radiological Science and Medical Imaging Department, College of Applied Medical Sciences, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia.
- Division of Neurology, Department of Brain Sciences, Faculty of Medicine, Imperial College London, London W12 0NN, UK.
- Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff CF24 4HQ, Wales, UK.
Förderung
- Prince Sattam bin Abdulaziz University
Zitieren
APA
Aljuhani, M., Ashraf, A., & Edison, P. (2024). Use of Artificial Intelligence in Imaging Dementia. Cells. https://doi.org/10.3390/cells13231965
Vancouver
Aljuhani M, Ashraf A, Edison P. Use of Artificial Intelligence in Imaging Dementia. Cells. 2024. doi:10.3390/cells13231965
BibTeX
@article{Aljuhani2024,
author = {Aljuhani, Manal and Ashraf, Azhaar and Edison, Paul},
title = {Use of Artificial Intelligence in Imaging Dementia},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13231965}
}
EUVIMED